Related Experiment Videos
Surgical approaches to dilated cardiomyopathy
1Section of Cardiac Surgery, University of Michigan, Taubman Health Care Center, 2120D, Box 0348, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0348, USA.
Insights
New surgical techniques for heart failure can improve survival and help patients avoid or postpone heart transplantation. These advanced procedures reshape the left ventricle, offering better outcomes for end-stage cardiomyopathy patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Heart Failure Research
Background:
- Heart failure is a leading cause of hospitalization in the U.S.
- Congestive heart failure involves cardiac remodeling and ventricular dilation.
- Secondary mitral regurgitation in end-stage cardiomyopathy has a poor prognosis.
Purpose of the Study:
- To explore alternative surgical approaches for end-stage heart failure.
- To improve survival rates in patients with severe cardiomyopathy.
- To offer options beyond heart transplantation.
Main Methods:
- Review of evolving surgical techniques for left ventricular remodeling.
- Mitral valve annuloplasty, Batista myoplasty, and cardiomyoplasty are discussed.
- Integration of these techniques with optimal medical management.
Main Results:
- Surgical interventions that alter left ventricular shape show promise.
- Improved survival rates observed with these combined approaches.
- Patients may avoid or delay the need for heart transplantation.
Conclusions:
- Alternative surgical strategies offer improved outcomes for heart failure patients.
- These methods provide viable options for those not eligible for transplantation.
- Optimized medical and surgical management enhances patient survival and quality of life.
Abstract:
Heart failure is one of the leading causes of hospitalization in the United States today. Congestive heart failure is a chronic progressive disease with the common central element being the remodeling of the cardiac chamber associated with ventricular dilation. Secondary mitral regurgitation is a complication of end-stage cardiomyopathy and is associated with a poor prognosis. Historically, these patients were not considered operative candidates due to the high morbidity and mortality in this patient population. Heart transplantation is now considered the standard of treatment for select patients with end-stage heart disease, however, it is only applicable to a small number of patients. In an effort to address this problem, newer and alternative surgical approaches are evolving, including mitral valve annuloplasty, the Batista myoplasty, and cardiomyoplasty. When these operative techniques that alter the shape of the left ventricle are utilized, in combination with optimal medical management for heart failure, survival is improved and patients can avoid or postpone transplantation.